Back
Alnylam Pharmaceuticals Stock Predictions
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
$236.59
Seasonality Move:
16.16%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Alnylam Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 29.6% based on the past 20 years of stock performance.
-
Alnylam Pharmaceuticals has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Alnylam Pharmaceuticals Stock Undervalued?The current Alnylam Pharmaceuticals [ALNY] share price is $232.75. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 29.6% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
-
Alnylam Pharmaceuticals has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
141.98
Prediction Charts
Market Cap:
30.1B
Price in USD:
232.75
Volume:
796.5K
Beta:
1.18
Technical Analysis
SMA50:
252.42
SMA100:
252.16
SMA200:
258.65
52-Wk Change:
61.17%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?Yes, Alnylam Pharmaceuticals is a publicly traded company.
-
What is the Alnylam Pharmaceuticals stock quote today?The Alnylam Pharmaceuticals stock price is 232.75 USD today.
-
How to buy Alnylam Pharmaceuticals stock online?You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-1 | 272.52 | 255.76 | 273.61 | 255.13 |
| Apr-2 | 252.90 | 266.83 | 267.29 | 252.07 |
| Apr-3 | 263.00 | 262.16 | 264.65 | 258.65 |
| Apr-4 | 257.14 | 235.74 | 259.16 | 235.57 |
| Apr-7 | 226.50 | 232.95 | 241.83 | 220.00 |
| Apr-8 | 246.15 | 224.32 | 246.15 | 220.42 |
| Apr-9 | 220.33 | 243.27 | 245.56 | 205.87 |
| Apr-10 | 235.22 | 226.28 | 235.33 | 214.76 |
| Apr-11 | 223.31 | 237.77 | 240.00 | 220.54 |
| Apr-14 | 241.83 | 240.01 | 241.83 | 234.18 |
| Apr-15 | 241.37 | 230.93 | 242.15 | 228.06 |
| Apr-16 | 230.98 | 230.50 | 234.50 | 225.84 |
| Apr-17 | 230.48 | 234.56 | 235.12 | 228.96 |
| Apr-21 | 230.36 | 232.75 | 237.77 | 228.28 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.38 per share, an increase this year of $0.96 per share, and an increase next year of $2.88 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.